144 related articles for article (PubMed ID: 27487147)
1. Significant impact of amount of PCR input templates on various PCR-based DNA methylation analysis and countermeasure.
Liu Z; Zhou J; Gu L; Deng D
Oncotarget; 2016 Aug; 7(35):56447-56455. PubMed ID: 27487147
[TBL] [Abstract][Full Text] [Related]
2. Nucleosomes correlate with in vivo progression pattern of de novo methylation of p16 CpG islands in human gastric carcinogenesis.
Lu ZM; Zhou J; Wang X; Guan Z; Bai H; Liu ZJ; Su N; Pan K; Ji J; Deng D
PLoS One; 2012; 7(4):e35928. PubMed ID: 22558275
[TBL] [Abstract][Full Text] [Related]
3. A 115-bp MethyLight assay for detection of p16 (CDKN2A) methylation as a diagnostic biomarker in human tissues.
Zhou J; Cao J; Lu Z; Liu H; Deng D
BMC Med Genet; 2011 May; 12():67. PubMed ID: 21569495
[TBL] [Abstract][Full Text] [Related]
4. Methylation of CpG islands of p16 associated with progression of primary gastric carcinomas.
Luo D; Zhang B; Lv L; Xiang S; Liu Y; Ji J; Deng D
Lab Invest; 2006 Jun; 86(6):591-8. PubMed ID: 16534497
[TBL] [Abstract][Full Text] [Related]
5. Large-scale characterization of DNA methylation changes in human gastric carcinomas with and without metastasis.
Liu Z; Zhang J; Gao Y; Pei L; Zhou J; Gu L; Zhang L; Zhu B; Hattori N; Ji J; Yuasa Y; Kim W; Ushijima T; Shi H; Deng D
Clin Cancer Res; 2014 Sep; 20(17):4598-612. PubMed ID: 25009298
[TBL] [Abstract][Full Text] [Related]
6. Methylation of p16 CpG islands associated with malignant transformation of gastric dysplasia in a population-based study.
Sun Y; Deng D; You WC; Bai H; Zhang L; Zhou J; Shen L; Ma JL; Xie YQ; Li JY
Clin Cancer Res; 2004 Aug; 10(15):5087-93. PubMed ID: 15297411
[TBL] [Abstract][Full Text] [Related]
7. Impact of
Ma WR; Xu P; Liu ZJ; Zhou J; Gu LK; Zhang J; Deng DJ
World J Gastroenterol; 2020 Jan; 26(2):184-198. PubMed ID: 31988584
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous detection of CpG methylation and single nucleotide polymorphism by denaturing high performance liquid chromatography.
Deng D; Deng G; Smith MF; Zhou J; Xin H; Powell SM; Lu Y
Nucleic Acids Res; 2002 Feb; 30(3):E13. PubMed ID: 11809901
[TBL] [Abstract][Full Text] [Related]
9. A panel of DNA methylated markers predicts metastasis of pN
Liu Z; Cheng X; Zhang L; Zhou J; Deng D; Ji J
Br J Cancer; 2019 Oct; 121(7):529-536. PubMed ID: 31431673
[TBL] [Abstract][Full Text] [Related]
10. Profile of aberrant CpG island methylation along multistep gastric carcinogenesis.
Kang GH; Lee S; Kim JS; Jung HY
Lab Invest; 2003 Apr; 83(4):519-26. PubMed ID: 12695555
[TBL] [Abstract][Full Text] [Related]
11. Promoter methylation of p16, Runx3, DAPK and CHFR genes is frequent in gastric carcinoma.
Hu SL; Kong XY; Cheng ZD; Sun YB; Shen G; Xu WP; Wu L; Xu XC; Jiang XD; Huang DB
Tumori; 2010; 96(5):726-33. PubMed ID: 21302620
[TBL] [Abstract][Full Text] [Related]
12. Effect of DNMT3A polymorphisms on CpG island hypermethylation in gastric mucosa.
Takano H; Shibata T; Nakamura M; Sakurai N; Hayashi T; Ota M; Nomura-Horita T; Hayashi R; Shimasaki T; Otsuka T; Tahara T; Arisawa T
BMC Med Genet; 2020 Oct; 21(1):205. PubMed ID: 33066747
[TBL] [Abstract][Full Text] [Related]
13. Detection of methylation of human p16(Ink4a) gene 5'-CpG islands by electrochemical method coupled with linker-PCR.
Hou P; Ji M; Ge C; Shen J; Li S; He N; Lu Z
Nucleic Acids Res; 2003 Aug; 31(16):e92. PubMed ID: 12907744
[TBL] [Abstract][Full Text] [Related]
14. Characterization of human gastric carcinoma-related methylation of 9 miR CpG islands and repression of their expressions in vitro and in vivo.
Du Y; Liu Z; Gu L; Zhou J; Zhu BD; Ji J; Deng D
BMC Cancer; 2012 Jun; 12():249. PubMed ID: 22703336
[TBL] [Abstract][Full Text] [Related]
15. Risk prediction of gastric cancer by analysis of aberrant DNA methylation in non-neoplastic gastric epithelium.
Tahara T; Arisawa T; Shibata T; Wang FY; Nakamura M; Sakata M; Nagasaka M; Takagi T; Kamiya Y; Fujita H; Nakamura M; Hasegawa S; Iwata M; Takahama K; Watanabe M; Hirata I; Nakano H
Digestion; 2007; 75(1):54-61. PubMed ID: 17438355
[TBL] [Abstract][Full Text] [Related]
16. Frequent p16 CpG island hypermethylation in primary remnant gastric cancer suggesting an independent carcinogenic pathway.
Mino A; Onoda N; Yashiro M; Aya M; Fujiwara I; Kubo N; Sawada T; Ohira M; Kato Y; Hirakawa K
Oncol Rep; 2006 Mar; 15(3):615-20. PubMed ID: 16465421
[TBL] [Abstract][Full Text] [Related]
17. Denaturing high-performance liquid chromatography (DHPLC) as a reliable high-throughput prescreening method for aberrant promoter methylation in cancer.
Betz B; Florl AR; Seifert HH; Dall P; Schulz WA; Niederacher D
Hum Mutat; 2004 Jun; 23(6):612-20. PubMed ID: 15146466
[TBL] [Abstract][Full Text] [Related]
18. In situ analysis of p16/INK4 promoter hypermethylation in esophageal carcinoma and gastric carcinoma.
Zhang F; Wang L; Wu PP; Yan ZW; Zheng L; Yu YY; Jiang XC
Chin J Dig Dis; 2004; 5(4):149-55. PubMed ID: 15612883
[TBL] [Abstract][Full Text] [Related]
19. CpG island methylation status in gastric carcinoma with and without infection of Epstein-Barr virus.
Chang MS; Uozaki H; Chong JM; Ushiku T; Sakuma K; Ishikawa S; Hino R; Barua RR; Iwasaki Y; Arai K; Fujii H; Nagai H; Fukayama M
Clin Cancer Res; 2006 May; 12(10):2995-3002. PubMed ID: 16707594
[TBL] [Abstract][Full Text] [Related]
20. Methylation-specific PCR.
Ku JL; Jeon YK; Park JG
Methods Mol Biol; 2011; 791():23-32. PubMed ID: 21913069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
